dalteparin has been researched along with Bilirubinemia in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, SY | 1 |
| Jeon, K | 1 |
| Kim, HJ | 1 |
| Kim, SM | 1 |
| Song, J | 1 |
| Ha, JM | 1 |
| Um, SW | 1 |
| Koh, WJ | 1 |
| Chung, MP | 1 |
| Kim, H | 1 |
| Kwon, OJ | 1 |
| Suh, GY | 1 |
1 other study available for dalteparin and Bilirubinemia
| Article | Year |
|---|---|
Antifactor Xa levels in critically ill Korean patients receiving enoxaparin for thromboprophylaxis: a prospective observational study.
Topics: Aged; Asian People; Critical Illness; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Female; Fibrinoly | 2013 |